Jennerex Biotherapeutics Obtains $21,600,000 New Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a8aa258b-5bfe-4a45-a604-cc208fa49073&Preview=1
Date
5/23/2013
Company Name
Jennerex Biotherapeutics
Mailing Address
450 Sansome St 16th Floor San Francisco, CA 94111
Company Description
Jennerex Biotherapeutics, Inc. is a biotechnology company focused on the development and commercialization of first-in-class, breakthrough targeted oncolytic immunotherapy products for solid tumors.
Website
http://www.jennerex.com
Transaction Type
Venture Equity
Transaction Amount
$21,600,000
Transaction Round
Undisclosed
Proceeds Purposes
This financing will enable us to expand our efforts to develop Pexa-Vec as a novel therapeutic option for liver cancer, our lead program, which represents the third most deadly cancer in the world.
M&A Terms
Venture Investor
Undisclosed